Lead Product(s): Trastuzumab
Therapeutic Area: Oncology Product Name: Herclon
Highest Development Status: Approved Product Type: Large molecule
Partner/Sponsor/Collaborator: F. Hoffmann-La Roche
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership June 17, 2020
Cipla entered a distribution agreement with Roche Products to expand scope of the partnership to include, marketing and distribution of Roche’s trademark oncology drugs - Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova) in India.